Perinatal lamb model of respiratory syncytial virus (RSV) infection

Viruses

Volumn 4, Issue 10, 2012, Pages 2359-2378

  Derscheid, Rachel J ^a   Ackermann, Mark R ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Airways; Bronchiolitis; Infants; Innate immunity; Lambs; Lung; Ovine; Perinatal; Premature; Preterm; Respiratory syncytial virus (RSV)

Indexed keywords

CELL PROTEIN; CHEMOKINE; CLARA CELL SECRETORY PROTEIN; DUAL OXIDASE 1; DUAL OXIDASE 2; FORMALIN INACTIVATED RESPIRATORY SYNCYTIAL VIRUS VACCINE; IMMUNOGLOBULIN; IODIDE; LACTOPEROXIDASE; MESSENGER RNA; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; SECRETORY PROTEIN; THIOCYANATE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADAPTIVE IMMUNITY; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BRONCHIOLE; BRONCHIOLITIS; CLARA CELL; COLOSTRUM; DENDRITIC CELL; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME INHIBITION; EPITHELIUM CELL; EXPOSURE; FEVER; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INNATE IMMUNITY; INOCULATION; LAMB; LUNG ALVEOLUS CELL TYPE 2; LUNG DEVELOPMENT; LUNG STRUCTURE; MALAISE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PREMATURITY; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; STAINING; SURVIVAL; T LYMPHOCYTE; TACHYPNEA; VIRAL TROPISM; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; IMMUNITY, INNATE; LACTOPEROXIDASE; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; SHEEP; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

ANIMALIA; BOVINAE; OVIS; OVIS ARIES; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84868121909     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4102359     Document Type: Article

References (95)

1. Nair, H.; Nokes, D.J.; Gessner, B.D.; Dherani, M.; Madhi, S.A.; Singleton, R.J.; O'Brien, K.L.; Roca, A.; Wright, P.F.; Bruce, N. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 2010, 375, 1545-1555.
2. Chanock, R.; Roizman, B.; Myers, R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am. J. Hyg. 1957, 66, 281-290.
3. Chanock, R.; Finberg, L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Ii. Epidemiologic aspects of infection in infants and young children. Am. J. Hyg. 1957, 66, 291-300.
4. Empey, K.M.; Peebles, R.S., Jr.; Kolls, J.K. Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin. Infect. Dis. 2010, 50, 1258-1267.
5. Meert, K.L.; Sarnaik, A.P.; Gelmini, M.J.; Lieh-Lai, M.W. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind, randomized trial. Crit. Care Med. 1994, 22, 566-572.
6. Wu, H.; Pfrarr, D.S.; Losonsky, G.A.; Kiener, P.A. Immunoprophylaxis of RSV infection: Advancing from RSV-IGIV to palivizumab and motavizumab. Curr. Top Microbiol. Immunol. 2008, 317, 103-123.
7. Olszweska, W.; Openshaw, P. Emerging drugs for respiratory syncytial virus infection. Expert Opin. Ermg. Drugs 2009, 14, 207-217.
8. Graham, B.S. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am. J. Respir. Crit. Care Med. 1995, 152, S63-S66.
9. Collins, P.L.; Melero, J.A. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Res. 2011, 162, 80-99.
10. Hon, K.L.; Leung, T.F.; Cheng, W.Y.; Ko, N.M.; Tang, W.K.; Wong, W.W.; Yeung, W.H.; Chan, P.K. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J. Crit. Care 2012, ePub ahead of print.
11. Sommer, C.; Resch, B.; Simoes, E.A. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. J. Open Microbiol. 2012, 5, 144-154.
12. Martin, J.A.; Hamilton, B.E.; Sutton, P.D.; Ventura, S.J.; Mathews, T.J.; Osterman, M.J. Births: Final data for 2008. Natl. Vital Stat. Rep. 2010, 59, 3-71.
13. Lawn, J.E.; Gravett, M.G.; Nunes, T.M.; Rubens, C.E.; Stanton, C. Global Report on Preterm Birth and Stillbirth (1 of 7): Definitions, Description of the Burden and Opportunities to Improve Data; Report; BMC: London, UK, 2010.
14. Belknap, E.B.; Ciszewski, D.K.; Baker, J.C. Experimental respiratory syncytial virus infection in calves and lambs. J. Vet. Diagn. Invest. 1995, 7, 285-298.
15. Cutlip, R.C.; Lehmkuhl, H.D. Lesions in lambs experimentally infected with bovine respiratory syncytial virus. Am. J. Vet. Res. 1979, 40, 1479-1482.
16. Lapin, C.D.; Hiatt, P.W.; Langston, C.; Mason, E.; Piedra, P.T. A lamb model for human respiratory syncytial virus infection. Pediatr. Pulmonol. 1993, 15, 151-156.
17. Lehmkuhl, H.D.; Cutlip, R.C. Experimental respiratory syncytial virus infection in feeder-age lambs. Am. J. Vet. Res. 1979, 40, 1729-1730.
18. Grubor, B.; Gallup, J.M.; Meyerholz, D.K.; Crouch, E.; Evans, R.B.; Brogden, K.A.; Lehmkuhl, H.D.; Ackermann, M.R. Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during paramyxoviral pneumonia in neonatal lambs. Clin. Vaccine Immunol. 2004, 11, 599-607.
19. Meyerholz, D.K.; Grubor, B.; Fach, S.J.; Sacco, R.E.; Lehmkuhl, H.D.; Gallup, J.M.; Ackermann, M.R. Reduced clearance of respiratory syncytial virus in a preterm lamb model. Microb. Infect. 2004, 6, 1312-1319.
20. Olivier, A.; Gallup, J.M.; de Macedo, M.M.; Varga, S.M.; Ackermann, M.R. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int. J. Exp. Pathol. 2009, 90, 431-438.
21. Johnson, J.E.; Gonzales, R.A.; Olson, S.J.; Wright, P.F.; Graham, B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 2007, 20, 108-119.
22. Burri, P.H. Fetal and postnatal development of the lung. Annu. Rev. Physiol. 1984, 46, 617-628.
23. Jeffery, P.K.; Gaillard, D.; Moret, S. Human airway secretory cells during development and in mature airway epithelium. Eur. Respir. J. 1992, 5, 93-104.
24. Lukacs, N.W.; Smitt, J.J.; Mukherjee, S.; Morris, S.B.; Nunez, G.; Lindell, D.M. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 2010, 185, 2231-2239.
25. Barth, P.J.; Wolf, M.; Ramaswamy, A. Distribution and number of clara cells in the normal and disturbed development of the human fetal lung. Pediatr. Pathol. 1994, 14, 637-651.
26. Boers, J.E.; Ambergen, A.W.; Thunnissen, F.B. Number and proliferation of clara cells in normal human airway epithelium. Am. J. Respir. Crit. Care Med. 1999, 159, 1585-1591.
27. Plopper, C.G.; Mariassy, A.T.; Hill, L.H. Ultrastructure of the nonciliated bronchiolar epithelial (clara) cell of mammalian lung: I. A comparison of rabbit, guinea pig, rat, hamster, and mouse. Exp. Lung. Res. 1980, 1, 139-154.
28. Bernard, A.; Thielemans, N.; Lauwerys, R.; Langhendries, J.P.; Van Lierde, M.; Freund, M.M. Clara cell protein in human amniotic fluid: a potential marker of fetal lung growth. Pediatr. Res. 1994, 36, 771-775.
29. Elizur, A.; Adair-Kirk, T.L.; Kelley, D.G.; Griffin, G.L.; de Mello, D.E.; Senior, R.M. Clara cells impact the pulmonary innate immune response to LPS. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293, L383-L392.
30. Wang, S.Z.; Rosenberger, C.L.; Bao, Y.X.; Stark, J.M.; Harrod, K.S. Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection. J. Immunol. 2003, 171, 1051-1060.
31. You, D.; Becnel, D.; Wang, K.; Ripple, M.; Daly, M.; Cormier, S.A. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir. Res. 2006, 7, 107-117.
32. Willems, F.; Vollstedt, S.; Suter, M. Phenotype and function of neonatal DC. Eur. J. Immunol. 2009, 39, 26-35.
33. Thornburg, N.J.; Shepherd, B.; Crowe, J.E., Jr. Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J. Virol. 2010, 84, 12895-12902.
34. Levy, O.; Martin, S.; Eichenwald, E.; Ganz, T.; Valore, E.; Carroll, S.F.; Lee, K.; Goldmann, D.; Thorne, G.M. Impaired innate immunity in the newborn: Newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999, 104, 1327-1333.
35. Ambruso, D.R.; Bentwood, B.; Henson, P.M.; Johnston, R.B., Jr. Oxidative metabolism of cord blood neutrophils: Relationship to content and degranulation of cytoplasmic granules. Pediatr. Res. 1984, 18, 1148-1153.
36. Qing, G.; Rajaraman, K.; Bortolussi, R. Diminished priming of neonatal polymorphonuclear leukocytes by lipopolysaccharide is associated with reduced CD14 expression. Infect. Immun. 1995, 63, 248-252.
37. Remijsen, Q.; Kuijpers, T.W.; Wirawan, E.; Lippens, S.; Vandenabeele, P.; Vanden Berghe, T. Dying for a cause: Netosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 2011, 18, 581-588.
38. Levy, O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7, 379-390.
39. Bem, R.A.; Domachowske, J.B.; Rosenberg, H.F. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 301, L148-L156.
40. Thomas, L.H.; Cook, R.S.; Howard, C.J.; Gaddum, R.M.; Taylor, G. Influence of selective T-lymphocyte depletion on the lung pathology of gnotobiotic calves and the distribution of different T-lymphocyte subsets following challenge with bovine respiratory syncytial virus. Res. Vet. Sci. 1996, 61, 38-44.
41. Kalina, W.V.; Woolums, A.R.; Berghous, R.D.; Gerswin, L.J. Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 2004, 22, 1465-1474.
42. Scheerlinck, J.P.; Snibson, K.J.; Bowles, V.M.; Sutton, P. Biomedical applications of sheep models: From asthma to vaccines. Trends Biotechnol. 2008, 26, 259-266.
43. Alcorn, D.G.; Adamson, T.M.; Maloney, J.E.; Robinson, P.M. A morphologic and morphometric analysis of fetal lung development in the sheep. Anat. Rec. 1981, 201, 655-667.
44. Flecknoe, S.L.; Wallace, M.J.; Cock, M.L.; Harding, R.; Hooper, S.B. Changes in alveolar epithelial cell proportions during fetal and postnatal development in sheep. Am. J. Physiol. Lung. Cell Mol. Physiol. 2003, 285, L664-L679.
45. Plopper, C.G.; Mariassy, A.T.; Lollini, L.O. Structure as revealed by airway dissection. A comparison of mammalian lungs. Am. Rev. Respir. Dis. 1983, 128, S4-S7.
46. Smith, L.J.; McKay, K.O.; van Asperen, P.P.; Selvadurai, H.; Fitzgerald, D.A. Normal development of the lung and premature birth. Paediatr. Respir. Rev. 2010, 11, 135-142.
47. Borthwick, D.W.; West, J.D.; Keighren, M.A.; Flockhart, J.H.; Innes, B.A.; Dorin, J.R. Murine submucosal glands are clonally derived and show a cystic fibrosis gene-dependent distribution pattern. Am J Resp Cell Mol Biol 1999, 20, 1181-1189.
48. Banfi, B. A novel host defense system of airways is defective in cystic fibrosis: Update. Am. J. Resp. Crit. Care Med. 2007, 175, 967.
49. Conner, G.E.; Salathe, M.; Forteza, R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am. J. Respir. Crit. Care Med. 2002, 166, S57-S61.
50. Conner, G.E.; Wijkstrom-Frei, C.; Randell, S.H.; Fernandez, V.E.; Salathe, M. The lactoperoxidase system links anion transport to host defense in cystic fibrosis. FEBS Lett. 2007, 581, 271-278.
51. Fischer, H. Mechanism and function of DUOX in epithelia of the lung. Antioxid. Redox. Signal 2009, 11, 2453-2465.
52. Ampuero, S.; Luchsinger, V.; Tapia, L.; Palomino, M.A.; Larranaga, C.E. Sp-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in chilean infants. Infect. Genet. Evol. 2011, 11, 1368-1377.
53. Forteza, R.; Salathe, M.; Miot, F.; Forteza, R.; Conner, G.E. Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2005, 32, 462-469.
54. Fragoso, M.A.; Fernandez, V.; Forteza, R.; Randell, S.H.; Salathe, M.; Conner, G.E. Transcellular thiocyanate transport by human airway epithelia. J. Physiol. 2004, 561, 183-194.
55. Furtmüller, P.G.; Jantschko, W.; Regelsberger, G.; Jakopitsch, C.; Arnhold, J.; Obinger, C. Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 2002, 41, 11895-11900.
56. Pedemonte, N.; Caci, E.; Sondo, E.; Caputo, A.; Rhoden, K.; Pfeffer, U.; Di Candia, M.; Bandettini, R.; Ravazzolo, R.; Zegarra-Moran, O.; et al. Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels. J. Immunol. 2007, 178, 5144-5153.
57. Wijkstrom-Frei, C.; El-Chemaly, S.; Ali-Rachedi, R.; Gerson, C.; Cobas, M.A.; Forteza, R.; Salathe, M.; Conner, G.E. Lactoperoxidase and human airway host defense. Am. J. Respir. Cell Mol. Biol. 2003, 29, 206-212.
58. Fischer, A.J.; Lennemann, N.J.; Krishnamurthy, S.; Pocza, P.; Durairaj, L.; Launspack, J.L.; Rhein, B.A.; Wohlford-Lenane, C.; Lorentzen, D.; Banfi, B.; et al. Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. Am. J. Respir. Cell Mol. Biol. 2011, 45, 874-881.
59. Geiszt, M.; Witta, J.; Baffi, J.; Lekstrom, K.; Leto, T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 2003, 17, 1502-1504.
60. Moskwa, P.; Lorentzen, D.; Excoffon, K.J.D.A.; Zabner, J.; McCray, P.B., Jr.; Nauseef, W.M.; Dupuy, C.; Banfi, B. A novel host defense system of airways is defective in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2007, 175, 174-183.
61. Fischer, H.; Gonzales, L.K.; Kolla, V.; Schwarzer, C.; Miot, F.; Illek, B.; Ballard, P.L. Developmental regulation of Duox1 expression and function in human fetal lung epithelial cells. Am. J. Physiol. Lung. Cell Mol. Physiol. 2007, 292, L1506-L1514.
62. Gerson, C.; Sabater, J.; Scuri, M.; Torbati, A.; Coffey, R.; Abraham, J.W.; Lauredo, I.; Forteza, R.; Wanner, A.; Salathe, M.; et al. The lactoperoxidase system function in bacterial clearance of airways. Am. J. Resir. Cell Mol. Biol. 2000, 22, 665-671.
63. Barth, P.J.; Koch, S.; Muller, B.; Unterstab, F.; von Wichert, P.; Moll, R. Proliferation and number of clara cell 10-kda protein (CC10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa. Virchows. Arch. 2000, 437, 648-655.
64. Plopper, C.G.; Hill, L.H.; Mariassy, A.T. Ultrastructure of the nonciliated bronchiolar epithelial (clara) cell of mammalian lung. A study of man with comparison of 15 mammalian species. Exp. Lung. Res. 1980, 1, 171-180.
65. Khoor, A.; Gray, M.E.; Singh, G.; Stahlman, M.T. Ontogeny of clara cell-specific protein and its mRNA: Their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J. Histochem. Cytochem. 1996, 44, 1429-1438.
66. Li, X.; Castleman, W.L. Effects of 4-ipomeanol on bovine parainfluenza type 3 virus-induced pneumonia in calves. Vet. Pathol. 1991, 28, 428-437.
67. Haynes, L.M.; Moore, D.D.; Kurt-Jones, E.A.; Finberg, R.W.; Anderson, L.J.; Tripp, R.A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 2001, 75, 10730-10737.
68. Liu, P.; Jamaluddin, M.; Li, K.; Garofalo, R.P.; Casola, A.; Brasier, A.R. Retinoic acid-inducible gene I mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 2007, 81, 1401-1411.
69. Scagnolari, C.; Midulla, F.; Pierangeli, A.; Moretti, C.; Bonci, E.; Berardi, R.; De Angelis, D.; Selvaggi, C.; Di Marco, P.; Girardi, E.; et al. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin. Vaccine Immunol. 2009, 16, 816-823.
70. Vareille, M.; Kieninger, E.; Edwards, M.R.; Regamey, N. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011, 24, 210-229.
71. Sow, F.B.; Gallup, J.M.; Derscheid, R.; Krishnan, S.; Ackermann, M.R. Ontogeny of the immune response in the ovine lung. Immunol. Invest. 2012, 41, 304-316.
72. Kawashima, K.; Meyerholz, D.K.; Gallup, J.M.; Grubor, B.; Lazic, T.; Lehmkuhl, H.D.; Ackermann, M.R. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol. 2006, 19, 316-323.
73. Meyerholz, D.K.; DeGraaff, J.A.; Gallup, J.M.; Ackermann, M.R. Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung. J. Histochem. Cytochem. 2006, 54, 1247-1253.
74. Sow, F.B.; Gallup, J.M.; Krishnan, S.; Patera, A.C.; Suzich, J.; Ackermann, M.R. Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Resp. Res. 2011, 12, 106.
75. Fach, S.J.; Olivier, A.; Gallup, J.M.; Waters, T.E.; Ackermann, M.R.; Lehmkuhl, H.D.; Sacco, R.E. Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet. Immunol. Immunopathol. 2010, 136, 55-64.
76. Fach, S.J.; Brockmeier, S.L.; Hobbs, L.A.; Lehmkuhl, H.D.; Sacco, S.E. Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue. Vet. Immunol. Immun. Pathol. 2007, 112, 171-182.
77. Fach, S.J.; Meyerholz, D.K.; Gallup, J.M.; Ackermann, M.R.; Lehmkuhl, H.D.; Sacco, R.E. Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 and IL-10 gene transcripts. Viral Immunol. 2007, 20, 119-130.
78. Sow, F.B.; Gallup, J.M.; Olivier, A.; Krishnan, S.; Patera, A.C.; Suzich, J.; Ackermann, M.R. Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2011, 300, L12-L24.
79. Meyerholz, D.K.; Kawashima, K.; Gallup, J.; Grubor, B.; Ackermann, M.R. Expression of innate immune genes (SP-AD, SBD-1, TLR4) by respiratory epithelia at preterm gestation is less than full-term. Dev. Comp. Immunol. 2006, 30, 1060-1069.
80. Kurt-Jones, E.A.; Popova, L.; Kwinn, L.; Haynes, L.M.; Jones, L.P.; Tripp, R.A.; Walsh, E.E.; Freeman, M.W.; Golenbock, D.T.; Anderson, L.J.; et al. Pattern recognition receptors tlr4 and cd14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1, 398-401.
81. Delgado, M.F.; Coviello, S.; Monsalvo, A.C.; Melendi, G.A.; Hernandez, J.Z.; Batalle, J.P.; Diaz, L.; Trento, A.; Chang, H.Y.; Mitzner, W.; et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 2009, 15, 34-41.
82. Olivier, A.; Gallup, J.M.; van Geelen, A.; Ackermann, M.R. Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus A2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp. Lung. Res. 2011, 37, 131-143.
83. Neilson, K.A.; Yunis, E.J. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr. Pathol. 1990, 10, 491-502.
84. Simoes, E.A.; Carbonell-Estrany, X.; Rieger, C.H.; Mitchell, I.; Fredrick, L.; Groothuis, J.R. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J. Allergy Clin. Immunol. 2010, 126, 256-262.
85. Meyerholz, D.K.; Gallup, J.M.; Lazic, T.; de Macedo, M.M.A.; Lehmkuhl, H.D.; Ackermann, M.R. Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of RSV infection. Viral. Immunology 2007, 20, 188-196.
86. DeVincenzo, J.P.; Wilkinson, T.; Vaishnaw, A.; Cehelsky, J.; Meyers, R.; Nochur, S.; Harrison, L.; Meeking, P.; Mann, A.; Moane, E.; et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 2010, 182, 1305-1314.
87. Kwilas, S.; Liesman, R.M.; Zhang, L.; Walsh, E.; Pickles, R.J.; Peeples, M.E. Respiratory syncytial virus grown in vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J. Virol. 2009, 83, 10710-10718.
88. Sow, F.B.; Gallup, J.M.; Meyerholz, D.K.; Ackermann, M.R. Gene profiling studies in the neonatal ovine lung show enhanced effects of VEGF on the immune response. Dev. Comp. Immunol. 2009, 33, 761-771.
89. Castillow, E.M.; Varga, S.M. Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. Future Virol. 2008, 3, 445-454.
90. Jones, B.G.; Sealy, R.E.; Rudraraju, R.; Traina-Dorge, V.L.; Finneryfrock, B.; Cook, A.; Takimoto, T.; Portner, A.; Hurwitz, J.L. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 2012, 30, 959-968.
91. Lazic, T.; Sow, F.B.; Van Geelen, A.; Meyerholz, D.K.; Gallup, J.M.; Ackermann, M.R. Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung. Alcohol 2011, 45, 673-680.
92. Lazic, T.; Wyatt, T.A.; Matic, M.; Meyerholz, D.K.; Grubor, B.; Gallup, J.M.; Kersting, K.W.; Imerman, P.M.; Almeida-De-Macedo, M.; Ackermann, M.R. Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol 2007, 41, 347-355.
93. LeVine, A.M.; Gwozdz, J.; Stark, J.; Bruno, M.; Whitsett, J.; Korfhagen, T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 1999, 103, 1015-1021.
94. LeVine, A.M.; Elliott, J.; Whitsett, J.A.; Srikiatkhachorn, A.; Crouch, E.; DeSilva, N.; Korfhagen, T. Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 2001, 31, 193-199.
95. Meehan, J.T.; Cutlip, R.C.; Lehmkuhl, H.D.; Kluge, J.P.; Ackermann, M.R. Infected cell types in ovine lung following exposure to bovine respiratory syncytial virus. Vet. Pathol. 1994, 31, 229-236.